BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 12874984)

  • 1. Assets for mastering media relations.
    Steinerman P
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE59-61. PubMed ID: 12874984
    [No Abstract]   [Full Text] [Related]  

  • 2. A primer for website design.
    Dysart J
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE55-8. PubMed ID: 12874983
    [No Abstract]   [Full Text] [Related]  

  • 3. The best companies bare all.
    Jacobs T
    Nat Biotechnol; 2004 Nov; 22(11):1363. PubMed ID: 15529156
    [No Abstract]   [Full Text] [Related]  

  • 4. ScanBalt coordinates intellectual property in Northern Europe.
    Sheridan C
    Nat Biotechnol; 2004 Mar; 22(3):355. PubMed ID: 15017988
    [No Abstract]   [Full Text] [Related]  

  • 5. Why media relations matter.
    Kureczka JE
    Nat Biotechnol; 2006 Apr; 24(4):387-9. PubMed ID: 16710903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Giving your spinout the right spin.
    McElroy D
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE39-41. PubMed ID: 12874978
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of competitive intelligence in biotech startups.
    Carlucci S; Page A; Finegold D
    Nat Biotechnol; 2005 May; 23(5):525-7. PubMed ID: 15942983
    [No Abstract]   [Full Text] [Related]  

  • 8. Promote yourself and your profession with sound bites.
    McCaffree J
    J Am Diet Assoc; 2006 May; 106(5):661-2. PubMed ID: 16647316
    [No Abstract]   [Full Text] [Related]  

  • 9. A voice with no words.
    Nat Biotechnol; 2008 Apr; 26(4):358. PubMed ID: 18391996
    [No Abstract]   [Full Text] [Related]  

  • 10. Mastering the key elements of working with the media.
    Cloud D
    Issue Brief Cent Medicare Educ; 2005; 5(9):1-6. PubMed ID: 15696642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Talking with the public--challenging the public scare.
    Sinemus K
    Biotechnol J; 2007 Sep; 2(9):1047. PubMed ID: 17768765
    [No Abstract]   [Full Text] [Related]  

  • 12. Filters for preparing to meet a venture capitalist.
    Christoffersen R
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE49-50. PubMed ID: 12874981
    [No Abstract]   [Full Text] [Related]  

  • 13. Marketing biotechnology with a Gallic flair.
    Jouanneau AC
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE36-7. PubMed ID: 12874977
    [No Abstract]   [Full Text] [Related]  

  • 14. Exiting this year and into the next.
    Nat Biotechnol; 2005 Dec; 23(12):1451. PubMed ID: 16333272
    [No Abstract]   [Full Text] [Related]  

  • 15. Convincing a venture capitalist to invest in your idea.
    Dooley JF; Dooley JF
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE45-8. PubMed ID: 12874980
    [No Abstract]   [Full Text] [Related]  

  • 16. Selling out.
    Martin JF
    Nat Biotechnol; 2010 Apr; 28(4):315-7. PubMed ID: 20383912
    [No Abstract]   [Full Text] [Related]  

  • 17. Biotechnology and the popular press: hype and the selling of science.
    Caulfield T
    Trends Biotechnol; 2004 Jul; 22(7):337-9. PubMed ID: 15245905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Earlier stage biotechs attract partners.
    Ratner M
    Nat Biotechnol; 2005 May; 23(5):509. PubMed ID: 15877052
    [No Abstract]   [Full Text] [Related]  

  • 19. Marriage guidance for collaborators.
    Hogan J
    Med Device Technol; 2005 Mar; 16(2):25-6. PubMed ID: 15828497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Communication of gene technology--a difficult enterprise: a journalist's view on biotech communication.
    Spahl T; Deichmann T
    Biotechnol J; 2007 Sep; 2(9):1064-6. PubMed ID: 17768770
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.